Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Omalizumab increased thresholds for reacting to peanut and other common allergenic foods during ...
Please provide your email address to receive an email when new articles are posted on . Researchers collected allergic reaction incidence using a monthly text message. Per 100 person-months, ...
A study led by Johns Hopkins Children's Center shows omalizumab—an injectable, Food and Drug Administration-approved medication for treating asthma and other allergic conditions—substantially reduced ...
A pair of new papers unlock crucial new insights into what goes on in the body when anaphylaxis occurs, and indicate how an existing asthma medication could one day help prevent these life-threatening ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results